Status | Study |
Completed |
Study Name: Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy Condition: Common Variable Immunodeficiency X-linked Agammaglobulinemia Date: 2007-10-11 Interventions: Biological: Human Normal Immunoglobulin for Subcutaneous Administration (IGSC) IgPro20 is a liquid formu |
Completed |
Study Name: Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency Condition: Common Variable Immunodeficiency Agammaglobulinemia Date: 2007-08-23 Interventions: Drug: Vivaglobin Human normal immunoglobulin G (IgG) for subcutaneous (SC) use. |
Completed |
Study Name: A Clinical Study of Intravenous Immunoglobulin Condition: Immunologic Deficiency Syndromes Date: 2007-05-01 Interventions: Drug: Immune Globulin Intravenous (Human) Omr-IgG-am IGIV IGIV infusions of 300-900 mg/kg every 3 or 4 w |
Completed |
Study Name: Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) Condition: Agammaglobulinemia IgG Deficiency Date: 2006-05-05 Interventions: Drug: Immunoglobulins Intravenous (Human) Liquid formulation; treatment schedule every 3 or 4 weeks usin |
Completed |
Study Name: Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. Condition: Primary Immunodeficiency Common Variable Hypogammaglobulinemia Date: 2006-01-18 Interventions: Biological: Gammaplex (Intravenous immunoglobulin) GAMMAPLEX 5g/100 mL, dose is 300-800 mg/kg/infusion e |
Completed |
Study Name: Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients Condition: Immunologic Deficiency Syndrome Agammaglobulinemia Date: 2005-09-13 Interventions: Drug: Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Puri |
Completed |
Study Name: Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) Condition: Agammaglobulinemia IgG Deficiency Date: 2005-09-12 Interventions: Drug: Immunoglobulins Intravenous (Human) |
Completed |
Study Name: Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID) Condition: Agammaglobulinemia IgG Deficiency Date: 2005-09-12 Interventions: Drug: Immunoglobulins Intravenous (Human) |
Completed |
Study Name: Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia) Condition: Hypogammaglobulinemia Agammaglobulinemia Date: 2005-09-08 Interventions: Drug: Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) |
Completed |
Study Name: Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients Condition: Hypogammaglobulinemia Date: 2005-08-29 Interventions: Drug: IVIG-L |